Home / Pharmaceutical / Senju Pharmaceutical Co., Ltd. - Product Pipeline Review - 2015

Senju Pharmaceutical Co., Ltd. - Product Pipeline Review - 2015

Published: Nov 2015 | No Of Pages: 35 | Published By: Global Markets Direct

Senju Pharmaceutical Co., Ltd. - Product Pipeline Review - 2015

Summary

Global Markets Direct's, 'Senju Pharmaceutical Co., Ltd. - Product Pipeline Review - 2015', provides an overview of the Senju Pharmaceutical Co., Ltd.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Senju Pharmaceutical Co., Ltd.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Senju Pharmaceutical Co., Ltd. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Senju Pharmaceutical Co., Ltd.'s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement
- Latest news and deals relating to the Senju Pharmaceutical Co., Ltd.'s pipeline products

Reasons to buy

- Evaluate Senju Pharmaceutical Co., Ltd.'s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Senju Pharmaceutical Co., Ltd. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Senju Pharmaceutical Co., Ltd.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Senju Pharmaceutical Co., Ltd. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Senju Pharmaceutical Co., Ltd.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Senju Pharmaceutical Co., Ltd. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues

Table of Contents
2
List of Tables 3
List of Figures 3
Neurodyn Inc. Snapshot 4
Neurodyn Inc. Overview 4
Key Information 4
Key Facts 4
Neurodyn Inc. - Research and Development Overview 5
Key Therapeutic Areas 5
Neurodyn Inc. - Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products - Monotherapy 8
Neurodyn Inc. - Pipeline Products Glance 9
Neurodyn Inc. - Clinical Stage Pipeline Products 9
Phase I Products/Combination Treatment Modalities 9
Neurodyn Inc. - Early Stage Pipeline Products 10
Preclinical Products/Combination Treatment Modalities 10
Neurodyn Inc. - Drug Profiles 11
Gln-1062 11
Product Description 11
Mechanism of Action 11
R&D Progress 11
ND-602 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
NQ-1123 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
Neurodyn Inc. - Pipeline Analysis 16
Neurodyn Inc. - Pipeline Products by Target 16
Neurodyn Inc. - Pipeline Products by Route of Administration 17
Neurodyn Inc. - Pipeline Products by Molecule Type 18
Neurodyn Inc. - Pipeline Products by Mechanism of Action 19
Neurodyn Inc. - Recent Pipeline Updates 20
Neurodyn Inc. - Dormant Projects 21
Neurodyn Inc. - Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Appendix 23
Methodology 23
Coverage 23
Secondary Research 23
Primary Research 23
Expert Panel Validation 23
Contact Us 23
Disclaimer 24

Fate Therapeutics, Inc., Key Information 5
Fate Therapeutics, Inc., Key Facts 5
Fate Therapeutics, Inc. - Pipeline by Indication, 2015 7
Fate Therapeutics, Inc. - Pipeline by Stage of Development, 2015 9
Fate Therapeutics, Inc. - Monotherapy Products in Pipeline, 2015 10
Fate Therapeutics, Inc. - Partnered Products in Pipeline, 2015 11
Fate Therapeutics, Inc. - Partnered Products/ Combination Treatment Modalities, 2015 12
Fate Therapeutics, Inc. - Phase II, 2015 13
Fate Therapeutics, Inc. - Phase I, 2015 14
Fate Therapeutics, Inc. - Preclinical, 2015 15
Fate Therapeutics, Inc. - Discovery, 2015 16
Fate Therapeutics, Inc. - Pipeline by Molecule Type, 2015 29
Fate Therapeutics, Inc. - Recent Pipeline Updates, 2015 30
Fate Therapeutics, Inc. - Dormant Developmental Projects,2015 33

Senju Pharmaceutical Co., Ltd. - Pipeline by Top 10 Indication, 2015 7
Senju Pharmaceutical Co., Ltd. - Pipeline by Stage of Development, 2015 8
Senju Pharmaceutical Co., Ltd. - Monotherapy Products in Pipeline, 2015 9
Senju Pharmaceutical Co., Ltd. - Partnered Products in Pipeline, 2015 10
Senju Pharmaceutical Co., Ltd. - Pipeline by Top 10 Target, 2015 26
Senju Pharmaceutical Co., Ltd. - Pipeline by Top 10 Route of Administration, 2015 27
Senju Pharmaceutical Co., Ltd. - Pipeline by Top 10 Molecule Type, 2015 28
Senju Pharmaceutical Co., Ltd. - Pipeline Products by Top 10 Mechanism of Action, 2015 29

Choose License Type
 
Contact Information
24/7 Research Support
Phone: +1-855-455-8662
sales@acutemarketreports.com
Get in Touch with us
join us on Facebook
Follow us on Twitter
Follow us on LinkedIn
Add us on Google +